Clinical Trials Directory

Trials / Completed

CompletedNCT03834610

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction: A Double-blinded Randomized Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Aswan University Hospital · Academic / Other
Sex
Male
Age
35 Years – 56 Years
Healthy volunteers
Accepted

Summary

Tadalafil is an effective oral therapy in erectile dysfunction. L-arginine is a pro drug that increase the level of nitrous oxide in the smooth muscles so can increase the strength and duration of erection. this clinical trials compare the daily oral L-arginine plus tadalafil in treatment of erectile dysfunction in diabetic patients.

Conditions

Interventions

TypeNameDescription
DRUGL-arginine 5 gm oral capsoral L-arginine 5 gm daily for 8 weeks
DRUGTadalafil 10 MGoral daily tadalafil 10mg for 8 weeks
DIAGNOSTIC_TESTserum testosterone levelmeasurement of serum testosterone level
DIAGNOSTIC_TESTHbA1Cmeasurement of HbA1C levels
DEVICEpenile dopplerpenile doppler to measure the degree of erection and penile vasculature

Timeline

Start date
2017-10-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2019-02-08
Last updated
2019-02-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03834610. Inclusion in this directory is not an endorsement.